Citation Impact
Citing Papers
The role of antioxidants and other agents in alleviating hyperglycemia mediated oxidative stress and injury in liver
2013
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Emerging inflammatory bowel disease in saudi outpatients: A report of 693 cases
2013
Dietary Advanced Glycation End Products and Their Potential Role in Cardiometabolic Disease in Children
2016 Standout
Global Prevalence of Helicobacter pylori Infection: Systematic Review and Meta-Analysis
2017 Standout
Epidemiology and risk factors for IBD
2015 Standout
Recent advances in nonalcoholic fatty liver disease
2010
Interaction between microbiota and immunity in health and disease
2020 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
The complexity of NF-κB signaling in inflammation and cancer
2013 Standout
Risk of chronic kidney disease in patients with non-alcoholic fatty liver disease: Is there a link?
2010
Brown adipose tissue clinical impact of a re-discovered thermogenic organ
2013
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
2016 Standout
Soluble form of a receptor for advanced glycation end products sRAGE as a biomarker
2010
Crohn's disease
2016 Standout
Antioxidant therapy for treatment of inflammatory bowel disease: Does it work?
2015 Standout
Melatonin Expresses Powerful Anti-inflammatory and Antioxidant Activities Resulting in Complete Improvement of Acetic-Acid-Induced Colitis in Rats
2010
Real-Time Noninvasive Imaging of Fatty Acid Uptake in Vivo
2012 StandoutNobel
Ulcerative colitis
2016 Standout
Ulcerative colitis
2020 Standout
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
Nonalcoholic fatty liver disease: A comprehensive review of a growing epidemic
2014
Non-alcoholic fatty liver disease and cardiovascular risk: Pathophysiological mechanisms and implications
2016
Melatonin treatment protects liver of Zucker rats after ischemia/reperfusion by diminishing oxidative stress and apoptosis
2012
The global burden of IBD: from 2015 to 2025
2015 Standout
Recent advances in nonalcoholic fatty liver disease
2009
NAFLD: A multisystem disease
2015 Standout
Fatty liver and lipotoxicity
2009
Globalisation of inflammatory bowel disease: perspectives from the evolution of inflammatory bowel disease in the UK and China
2016
What Is the Significance of Soluble and Endogenous Secretory Receptor for Advanced Glycation End Products in Liver Steatosis in Obese Prepubertal Children?
2010
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
The Codon 72 Polymorphism of p53 Regulates Interaction with NF-κB and Transactivation of Genes Involved in Immunity and Inflammation
2011
Circulating Levels of FGF-21 in Obese Youth: Associations With Liver Fat Content and Markers of Liver Damage
2013
The Impact of Inflammatory Bowel Disease in Canada 2018: Epidemiology
2018
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities
2021
Thyroid Hormone Regulation of Metabolism
2014 Standout
Inhibition of matrix metalloproteinase‐9 and nuclear factor kappa B contribute to melatonin prevention of motility and invasiveness in H epG 2 liver cancer cells
2013
The Role of Oxidative Stress and Antioxidants in Liver Diseases
2015 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Works of Özlen Atuğ being referenced
Serum concentrations of human angiopoietin-like protein 3 in patients with nonalcoholic fatty liver disease: association with insulin resistance
2009
Preliminary evidence of a reduced serum level of fibroblast growth factor 19 in patients with biopsy-proven nonalcoholic fatty liver disease
2012
Clinical Characteristics of Inflammatory Bowel Disease in Turkey
2008
Melatonin ameliorates methionine‐ and choline‐deficient diet‐induced nonalcoholic steatohepatitis in rats
2009
R72P Polymorphism of TP53 in Ulcerative Colitis Patients is Associated with the Incidence of Colectomy, Use of Steroids and the Presence of a Positive Family History
2010
Decreased plasma levels of soluble receptor for advanced glycation endproducts (sRAGE) in patients with nonalcoholic fatty liver disease
2009
Association between the presence of brown adipose tissue and non‐alcoholic fatty liver disease in adult humans
2011